Elevated Levels of Soluble CD147 are Associated with Hyperinflammation and Disease Severity in COVID-19: A Proof-of-Concept Clinical Study

To evaluate soluble CD147 levels in COVID-19 and identify whether these are associated with hyperinflammation and disease severity. One-hundred and nine COVID-19 patients and 72 healthy blood donors were studied. Levels of CD147, matrix metalloproteases (MMP) and inflammatory markers were measured o...

Descripción completa

Detalles Bibliográficos
Autores principales: Springall, Rashidi, González-Flores, Julieta, García-Ávila, Carlos, Juárez-Vicuña, Yaneli, Hernández-Diazcouder, Adrián, Márquez-Velasco, Ricardo, Cásares-Alvarado, Sergio, Sánchez-Muñoz, Fausto, Basilio-Gálvez, Edna, Castillo-Salazar, Mauricio, Ballinas-Verdugo, Martha A., Brianza-Padilla, Malinalli, Sánchez-Gloria, José L., Tavera-Alonso, Claudia, Sandoval, Julio, González-Pacheco, Héctor, Amezcua-Guerra, Luis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362089/
https://www.ncbi.nlm.nih.gov/pubmed/35920943
http://dx.doi.org/10.1007/s00005-022-00657-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362089/
https://www.ncbi.nlm.nih.gov/pubmed/35920943
http://dx.doi.org/10.1007/s00005-022-00657-6

Ejemplares similares